The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bensinger, S. J.
Right arrow Articles by Turka, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bensinger, S. J.
Right arrow Articles by Turka, L. A.
The Journal of Immunology, 2004, 172: 5287-5296.
Copyright © 2004 by The American Association of Immunologists

Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells1

Steven J. Bensinger2,*, Patrick T. Walsh2,*, Jidong Zhang*, Martin Carroll*, Ramon Parsons{dagger}, Jeffrey C. Rathmell{ddagger}, Craig B. Thompson{ddagger}, Matthew A. Burchill§, Michael A. Farrar§ and Laurence A. Turka*

* Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104; {dagger} Department of Pathology and Medicine, Columbia University, New York, NY 10032; {ddagger} Abramson Family Cancer Research Institute, Departments of Cancer Biology and Medicine, University of Pennsylvania, Philadelphia, PA 19104; and § Center for Immunology, Cancer Center, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455

Despite expression of the high-affinity IL-2R, CD4+CD25+ regulatory T cells (Tregs) are hypoproliferative upon IL-2R stimulation in vitro. However the mechanisms by which CD4+CD25+ T cells respond to IL-2 signals are undefined. In this report, we examine the cellular and molecular responses of CD4+CD25+ Tregs to IL-2. IL-2R stimulation results in a G1 cell cycle arrest, cellular enlargement and increased cellular survival of CD4+CD25+ T cells. We find a distinct pattern of IL-2R signaling in which the Janus kinase/STAT pathway remains intact, whereas IL-2 does not activate downstream targets of phosphatidylinositol 3-kinase. Negative regulation of phosphatidylinositol 3-kinase signaling and IL-2-mediated proliferation of CD4+CD25+ T cells is inversely associated with expression of the phosphatase and tensin homologue deleted on chromosome 10, PTEN.




This article has been cited by other articles:


Home page
J. Immunol.Home page
B. B. L. Pillemer, Z. Qi, B. Melgert, T. B. Oriss, P. Ray, and A. Ray
STAT6 Activation Confers upon T Helper Cells Resistance to Suppression by Regulatory T Cells
J. Immunol., July 1, 2009; 183(1): 155 - 163.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Andre, D. F. Tough, S. Lacroix-Desmazes, S. V. Kaveri, and J. Bayry
Surveillance of Antigen-Presenting Cells by CD4+CD25+ Regulatory T Cells in Autoimmunity: Immunopathogenesis and Therapeutic Implications
Am. J. Pathol., May 1, 2009; 174(5): 1575 - 1587.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Kamimura and M. J. Bevan
Endoplasmic Reticulum Stress Regulator XBP-1 Contributes to Effector CD8+ T Cell Differentiation during Acute Infection
J. Immunol., October 15, 2008; 181(8): 5433 - 5441.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Serafini, S. Mgebroff, K. Noonan, and I. Borrello
Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells
Cancer Res., July 1, 2008; 68(13): 5439 - 5449.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Bessoles, F. Fouret, S. Dudal, G. S. Besra, F. Sanchez, and V. Lafont
IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines
J. Leukoc. Biol., July 1, 2008; 84(1): 224 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. F. Zheng, G. J. Jones, M. Shi, J. C. D. Wiseman, K. J. Marr, B. M. Berenger, S. M. Huston, M. J. Gill, A. M. Krensky, P. Kubes, et al.
Late Expression of Granulysin by Microbicidal CD4+ T Cells Requires PI3K- and STAT5-Dependent Expression of IL-2R{beta} That Is Defective in HIV-Infected Patients
J. Immunol., June 1, 2008; 180(11): 7221 - 7229.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Haxhinasto, D. Mathis, and C. Benoist
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
J. Exp. Med., March 17, 2008; 205(3): 565 - 574.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. L. Sumpter, K. K. Payne, and D. S. Wilkes
Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25- helper T cells
J. Leukoc. Biol., March 1, 2008; 83(3): 708 - 717.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Marzec, K. Halasa, M. Kasprzycka, M. Wysocka, X. Liu, J. W. Tobias, D. Baldwin, Q. Zhang, N. Odum, A. H. Rook, et al.
Differential Effects of Interleukin-2 and Interleukin-15 versus Interleukin-21 on CD4+ Cutaneous T-Cell Lymphoma Cells
Cancer Res., February 15, 2008; 68(4): 1083 - 1091.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Marzec, X. Liu, M. Kasprzycka, A. Witkiewicz, P. N. Raghunath, M. El-Salem, E. Robertson, N. Odum, and M. A. Wasik
IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes
Blood, February 15, 2008; 111(4): 2181 - 2189.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Zeiser, D. B. Leveson-Gower, E. A. Zambricki, N. Kambham, A. Beilhack, J. Loh, J.-Z. Hou, and R. S. Negrin
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Blood, January 1, 2008; 111(1): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Quintarelli, J. F. Vera, B. Savoldo, G. M. P. Giordano Attianese, M. Pule, A. E. Foster, H. E. Heslop, C. M. Rooney, M. K. Brenner, and G. Dotti
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes
Blood, October 15, 2007; 110(8): 2793 - 2802.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Yates, F. Rovis, P. Mitchell, B. Afzali, J.-S Tsang, M. Garin, R. Lechler, G. Lombardi, and O. Garden
The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro
Int. Immunol., June 1, 2007; 19(6): 785 - 799.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Andersson, I. Stefanova, G. L. Stephens, and E. M. Shevach
CD4+CD25+ regulatory T cells are activated in vivo by recognition of self
Int. Immunol., April 1, 2007; 19(4): 557 - 566.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Bayer, A. Yu, and T. R. Malek
Function of the IL-2R for Thymic and Peripheral CD4+CD25+ Foxp3+ T Regulatory Cells
J. Immunol., April 1, 2007; 178(7): 4062 - 4071.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. K. Crellin, R. V. Garcia, and M. K. Levings
Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells
Blood, March 1, 2007; 109(5): 2014 - 2022.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Arruvito, M. Sanz, A. H. Banham, and L. Fainboim
Expansion of CD4+CD25+and FOXP3+ Regulatory T Cells during the Follicular Phase of the Menstrual Cycle: Implications for Human Reproduction
J. Immunol., February 15, 2007; 178(4): 2572 - 2578.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Burchill, J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar
IL-2 Receptor beta-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells
J. Immunol., January 1, 2007; 178(1): 280 - 290.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Battaglia, A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M.-G. Roncarolo
Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients
J. Immunol., December 15, 2006; 177(12): 8338 - 8347.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Buckler, P. T. Walsh, P. M. Porrett, Y. Choi, and L. A. Turka
Cutting Edge: T Cell Requirement for CD28 Costimulation Is Due to Negative Regulation of TCR Signals by PTEN
J. Immunol., October 1, 2006; 177(7): 4262 - 4266.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Zorn, E. A. Nelson, M. Mohseni, F. Porcheray, H. Kim, D. Litsa, R. Bellucci, E. Raderschall, C. Canning, R. J. Soiffer, et al.
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
Blood, September 1, 2006; 108(5): 1571 - 1579.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. P. Hickman, J. Yang, R. M. Thomas, A. D. Wells, and L. A. Turka
Defective Activation of Protein Kinase C and Ras-ERK Pathways Limits IL-2 Production and Proliferation by CD4+CD25+ Regulatory T Cells
J. Immunol., August 15, 2006; 177(4): 2186 - 2194.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Sugimoto, T. Oida, K. Hirota, K. Nakamura, T. Nomura, T. Uchiyama, and S. Sakaguchi
Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis
Int. Immunol., August 1, 2006; 18(8): 1197 - 1209.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Y.-S. Tsang, N. O. S. Camara, E. Eren, H. Schneider, C. Rudd, G. Lombardi, and R. Lechler
Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells
J. Leukoc. Biol., July 1, 2006; 80(1): 145 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. R. Mayack and L. J. Berg
Cutting Edge: An Alternative Pathway of CD4+ T Cell Differentiation Is Induced Following Activation in the Absence of {gamma}-Chain-Dependent Cytokine Signals
J. Immunol., February 15, 2006; 176(4): 2059 - 2063.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Li, W. R. Godfrey, S. B. Porter, Y. Ge, C. H. June, B. R. Blazar, and V. A. Boussiotis
CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy
Blood, November 1, 2005; 106(9): 3068 - 3073.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Acres, M. Gantzer, C. Remy, N. Futin, N. Accart, O. Chaloin, J. Hoebeke, J.-M. Balloul, and S. Paul
Fusokine Interleukin-2/Interleukin-18, a Novel Potent Innate and Adaptive Immune Stimulator with Decreased Toxicity
Cancer Res., October 15, 2005; 65(20): 9536 - 9546.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-X. Wang, S. Shu, and G. E. Plautz
Host Lymphodepletion Augments T Cell Adoptive Immunotherapy through Enhanced Intratumoral Proliferation of Effector Cells
Cancer Res., October 15, 2005; 65(20): 9547 - 9554.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
S. P Hickman and L. A Turka
Homeostatic T cell proliferation as a barrier to T cell tolerance
Phil Trans R Soc B, September 29, 2005; 360(1461): 1713 - 1721.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Baratelli, Y. Lin, L. Zhu, S.-C. Yang, N. Heuze-Vourc'h, G. Zeng, K. Reckamp, M. Dohadwala, S. Sharma, and S. M. Dubinett
Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells
J. Immunol., August 1, 2005; 175(3): 1483 - 1490.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Battaglia, A. Stabilini, and M.-G. Roncarolo
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
Blood, June 15, 2005; 105(12): 4743 - 4748.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. T. Duthoit, D. J. Mekala, R. S. Alli, and T. L. Geiger
Uncoupling of IL-2 Signaling from Cell Cycle Progression in Naive CD4+ T Cells by Regulatory CD4+CD25+ T Lymphocytes
J. Immunol., January 1, 2005; 174(1): 155 - 163.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.